Cyclosporin A: recent developments in the mechanism of action and clinical application

This publication has 24 references indexed in Scilit:

• Intralesional cyclosporin in psoriasis: effects on T lymphocyte and dendritic cell subpopulations
  British Journal of Dermatology, 2006
• The influence of cyclosporin A on the alternative pathways of human T cell activation in vitro
  European Journal of Immunology, 1989
• Effect of cyclosporin on interleukin 2-related T-lymphocyte parameters in IDDM patients
  Diabetes, 1989
• Ciclosporin in the Treatment of Nephrosis
  American Journal of Nephrology, 1989
• Inhibition of Histamine and Prostaglandin D2 Release from Human Lung Mast Cells by Ciclosporin A
  International Archives of Allergy and Immunology, 1989
• In situ hybridization for interleukin 2 and interleukin 2 receptor mRNA in T cells activated in the presence or absence of cyclosporin A.
  The Journal of Experimental Medicine, 1988
• Production of tumor necrosis factor/cachectin by human B cell lines and tonsillar B cells.
  The Journal of Experimental Medicine, 1988
• Inhibition of insulin release in vitro mediated by mononuclear cells from diabetic patients treated with cyclosporin A or placebo
  Diabetes, 1988
• Factors Associated with Early Remission of Type I Diabetes in Children Treated with Cyclosporine
  New England Journal of Medicine, 1988
• Low-dose cyclosporin A in severe psoriasis. A double-blind study
  British Journal of Dermatology, 1988